ATTO Conversion Disclosure
Goldman Sachs Group Inc · SEC Form 4 · Filed Aug 28, 2026
Conversion
Calculated transaction value
$0
Goldman Sachs Group Inc Other
ATTO
Transaction date
Aug 6, 2026
Public filing date
Aug 28, 2026
Filing lag
Filed 22 days later
ATTO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series C Preferred Stock on Common Stock
- Quantity / price
- 4,445,275 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4/A
- Filing identifier
- 0000886982-26-000522
Filing cohort
Transactions in this filing
Showing 15 of 35
Trades
35
Issuers
1
Estimated value
$14.78M
Buys / sales
8 / 23
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Buy | Aug 6, 2026 | $8.5M |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO Current | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $25.77K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $15.45K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $29.34K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $4.41K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $8.81K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $2.2K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $1.61M |
| Attovia Therapeutics, Inc. ATTO | Buy | Aug 5, 2026 | $242.44K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $22.93K |
| Attovia Therapeutics, Inc. ATTO | Sale | Aug 5, 2026 | $16.54K |